{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["3(1)"],"submitter":["Galipeau N"],"funding":["Novartis Pharmaceuticals Corporation"],"pubmed_abstract":["<h4>Background</h4>Patients with breast cancer experience a variety of disease symptoms and treatment-related side effects that can adversely affect functioning. The breast cancer experience may differ across disease stages and biomarker subtypes. This study identified relevant disease symptoms, treatment-related side effects, and physical functioning impacts in women with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer.<h4>Methods</h4>One-on-one concept elicitation interviews were conducted with 15 patients with HR+/HER2- advanced breast cancer. Open-ended questions about patient experience with breast cancer and its treatment were drawn from a semi-structured interview guide. All interviews were audio-recorded and transcrib"],"journal":["Journal of patient-reported outcomes"],"pagination":["10"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6367496"],"repository":["biostudies-literature"],"pubmed_title":["Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings."],"pmcid":["PMC6367496"],"pubmed_authors":["Tang DH","Revicki DA","Klooster B","Krohe M","Galipeau N","Cella D"],"additional_accession":[]},"is_claimable":false,"name":"Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings.","description":"<h4>Background</h4>Patients with breast cancer experience a variety of disease symptoms and treatment-related side effects that can adversely affect functioning. The breast cancer experience may differ across disease stages and biomarker subtypes. This study identified relevant disease symptoms, treatment-related side effects, and physical functioning impacts in women with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer.<h4>Methods</h4>One-on-one concept elicitation interviews were conducted with 15 patients with HR+/HER2- advanced breast cancer. Open-ended questions about patient experience with breast cancer and its treatment were drawn from a semi-structured interview guide. All interviews were audio-recorded and transcrib","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Feb","modification":"2026-07-16T20:28:00.091Z","creation":"2019-08-04T07:35:30Z"},"accession":"S-EPMC6367496","cross_references":{"pubmed":["30734110"],"doi":["10.1186/s41687-019-0098-1"]}}